COGT
Cogent Biosciences, Inc.
Stock
$31.02−0.57 (−1.80%)Close Oct 2, 2026
- Operating income, 2025
- −$333M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$333M | — |
| 2024 | −$276M | — |
| 2023 | −$208M | — |
| 2022 | −$148M | — |
| 2021 | −$76M | — |
| 2020 | −$82M | — |
| 2019 | −$32M | — |
| 2018 | −$36M | — |
| 2017 | −$26M | — |